PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 266 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $271 | -95.6% | 6,645 | -95.8% | 0.00% | -96.6% |
| Q4 2022 | $6,166 | -99.5% | 159,722 | +624.8% | 0.09% | +569.2% |
| Q3 2022 | $1,172,000 | +9.3% | 22,037 | +15.0% | 0.01% | +85.7% |
| Q3 2021 | $1,072,000 | -67.5% | 19,157 | -64.7% | 0.01% | -76.7% |
| Q2 2021 | $3,295,000 | +991.1% | 54,304 | +584.1% | 0.03% | +114.3% |
| Q3 2019 | $302,000 | -10.7% | 7,938 | +0.9% | 0.01% | -70.8% |
| Q4 2018 | $338,000 | – | 7,866 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |